Skip to main content
  • Home
  • About Us
  • Advisory Board
  • Advertise
  • Editorial Submissions
  • Contact Us
  • Subscribe to Newsletter

  • Follow me on Twitter
  • Friend me on Facebook
  • Connect with me on LinkedIn
  • Subscribe to me on YouTube
  • Subscribe to my RSS Feed

Menu

Skip to content
  • MedTech Economics
  • Policy
  • Manufacturing Execution
  • Product Design & Development
  • Quality & Compliance
  • Digital Health
  • Resource Library
  • Events & Webinars
MTI Resources

Sponsored by:
Sponsored by Celegence

Post-Market Surveillance

Featured Content

August 20, 2026 | By Binitkumar M. Vaghani

AI-Assisted Triage: Accelerating Post-Market Surveillance While Eliminating Reporting Blind Spots

August 19, 2026 | By Dr. Padmalakshmi Jnaneshwar

Devices are Getting Smarter, Making Materiovigilance Evolve Faster

August 9, 2026 | By Aalap Patel, MS, CQE, CSSBB

Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible

July 7, 2026 | By Aalap Patel, MS, CQE, CSSBB

From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance

April 20, 2026 | By Jonathan Messer

Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices

February 3, 2026 | By Pujitha Gourabathini

AI in Medical Devices: Safety Questions the Industry Can’t Afford to Ignore

June 6, 2024 | By Amelia Hufford, PhD, Phillip Stoltzfus

Reliable Active Surveillance: RWE for MedTech

Related Blogs

Europe PMC Integration in CAPTIS™
AI-Powered Solutions for Regulatory Compliance in the Medical Device Industry

PMCF under EU MDR
Strategies for Successful Post-Market Clinical Follow-Up (PMCF) under EU MDR: Insights from a Comprehensive Webinar

Guidelines for Systematic Reviews
Helpful Guidelines for Producing Your Systematic Reviews

Europe PMC Integration in CAPTIS™
Leveraging Technology to Optimize MDR Compliance Outsourcing & Partnership – Acumed

PMCF Insights
Insights into PMCF Requirements under EU MDR

Post-Market Clinical Follow-up
The Importance of Post-Market Clinical Follow-up for Medical Devices: Compliance and Beyond

Celegence Regulatory Soultions

Case Studies

PMS Report & PMCF Surveys

PMS Support & PMCF Surveys for a global Device Manufacturer


Project Summary: Long-term partnership between Celegence and a leading manufacturer of esthetic surgery devices for support with PMS and Clinical Evaluation documentation for complying with regulatory requirements of multiple countries/regions across the globe.

Clinical Evaluation & Support for an Emergency Use Medical Device


Project Summary: Manufacturers of a Class IIb emergency-use medical device required support in addressing observations from their Notified Body. The scope of work included advisory consulting for EU MDR compliance and medical writing support for Quality and Regulatory documentation.

Technology for EU MDR / IVDR Compliance

Europe PMC Integration in CAPTIS™
Europe PMC Integration in CAPTIS™

Time Saving in Literature Reviews with CAPTIS
Time Saving in Literature Reviews with CAPTIS

Data Extraction Tables in CAPTIS™
Data Extraction Tables in CAPTIS™

On-Demand Learning

PMCF under EU MDR

CER & PMS Document Writing

 

Leveraging Technology to Optimize MDR Compliance Outsourcing & Partnership

Leveraging Technology to Optimize MDR Compliance Outsourcing & Partnership

Sponsored By Celegence

Download this case study for insights on optimized regulatory processes via tech-enabled services from Celegence. Acumed made their MDR compliance a success by boosting efficiency, saving time, and streamlining collaboration.

Read More

Medical Device Services

  • Post-Market Clinical Follow-up Guidance 
  • EU MDR Gap Analysis
  • UDI Consulting
  • CER / CEP Writing
  • Post-Market Surveillance
  • Medical Device Consulting
  • IVDR Consulting
  • EU Authorized Representatives Services

Regulatory Updates

FDA Updates Recognized Consensus Standards Database with List 61
FDA Issues a Final Rule Amending the Quality System Regulation (QSR)
FDA Scheduled Updates for the CDRH Customer Collaboration Portal Including New Features
An Inside Look: Formal Meetings Between PDUFA Product Sponsors or Applicants and the FDA

Featured Articles

November 16, 2026

Beyond the Algorithm: Building AI Devices Clinicians Can Trust

By Bethany Chung, Ph.D.

Can clinicians trust an AI-enabled medical device to perform reliably for the patients they treat? The answer starts with who is represented in the training data, how the device performs in clinical settings, and what manufacturers monitor after launch.

November 9, 2026

What a Predetermined Change Control Plan Would Look Like for a Contocracy’s AI Stand-In

By Nicolas Edward Pendland

Contocracy, a form of rule proposed in 2026, gives one...

October 8, 2026

Cybersecurity by Design: Building Traceable Execution Across the MedTech Lifecycle

How MedTech manufacturers can move cybersecurity upstream, strengthen traceability, and prepare for faster vulnerability response.

September 21, 2026
Product Development, Human factors engineering

Reverse Engineering in Medical Device Design: When and Why It Makes Sense

By Khushali Solanki

Reverse engineering carries a reputation problem in medical device circles; it sounds like copying. In practice, it's a legitimate engineering discipline with specific, defensible use cases: replacing obsolete components, improving an existing design's manufacturability, and indigenizing imported parts. This article looks at when reverse engineering genuinely makes sense in medical device development, the technical process involved, and the intellectual property considerations teams need to navigate before using it.

August 20, 2026

AI-Assisted Triage: Accelerating Post-Market Surveillance While Eliminating Reporting Blind Spots

By Binitkumar M. Vaghani

Complaint volumes have outgrown manual triage, and medical device companies are turning to AI to keep up. The speed gains are real, but used carelessly the same tools can bury a reportable event at the bottom of a queue while the MDR clock runs. This piece maps where AI genuinely helps in post-market surveillance, where human judgment has to stay, and what validation, monitoring, and audit trails a defensible program needs. It is grounded in the current regulatory frame, including the QMSR and FDA's new inspection program (CP 7382.850) that took effect February 2, 2026, 21 CFR Part 803 reporting timelines, and ISO 13485 software validation expectations. It includes a practical table drawing the line between tasks that are safe to automate and decisions that must stay human-owned. The intended audience is quality, regulatory, and post-market surveillance professionals in the medical device industry.

August 19, 2026

Sensors at the Edge: Powering Smarter Healthcare

By Daraius Patell

As healthcare shifts towards remote monitoring, connected devices and decentralized care, sensor technologies are becoming increasingly foundational to how medical devices collect, validate and transmit critical information. From remote patient monitoring and at-home care to connected medical devices and robotic-assisted surgery, sensing technologies can help enable earlier detection, more reliable clinical data and better-informed decision making.

August 19, 2026

Devices are Getting Smarter, Making Materiovigilance Evolve Faster

By Dr. Padmalakshmi Jnaneshwar

According to Deloitte, only 22% of life sciences leaders say they have successfully scaled AI, and just 9% report achieving significant returns. For materiovigilance, this highlights the growing gap between execution and team expectations. Within this gap, fragmented data and manual processes continue to slow response times and increase compliance risk, creating a disconnect between the promise of real-time safety monitoring and operational reality. How can organizations close this execution gap and evolve materiovigilance from a reactive compliance function into a proactive, data-driven discipline?

August 18, 2026

FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices

GenAI-enabled medical devices hold transformative promise for patient care and the broader health ecosystem. At the same time, these devices may introduce unique risks when compared to traditional software and AI-enabled medical devices.  

View More Combination Products Articles »

TOPICS

  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory

Upcoming Events & Webinars

December 17, 2026 – 9:00 am – 10:00 am
How to Prevent and Handle Conformity Assessment Body Nonconformities

Contact Us

  • Advertising Opportunities
  • Editorial Submissions
  • General Inquiries
  • Privacy Policy
  • Cookie Policy
  • Sign Up for Newsletters

Innovative Publishing Company, Inc.

  • FoodSafetyTech
  • Food Safety Consortium Conference & Expo
  • MedTech Intelligence
  • Cannabis Industry Journal

© Copyright 2015 - 2026 Innovative Publishing Co., Inc., All Rights Reserved

Other Innovative Publishing Co., Inc. Sites: Food Safety Tech  |  Cannabis Industry Journal

Boost Product Quality with Integrated ALM and PLM
Whether you’re managing complex product portfolios, navigating regulatory pressures, or striving to deliver higher customer satisfaction, this guide will help you understand the tangible benefits of integrating ALM and PLM.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

MedTech Intelligence
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

We use tracking pixels that set your arrival time at our website, this is used as part of our anti-spam and security measures. Disabling this tracking pixel would disable some of our security measures, and is therefore considered necessary for the safe operation of the website. This tracking pixel is cleared from your system when you delete files in your history.

We also use cookies to store your preferences regarding the setting of 3rd Party Cookies.

Cookie Policy

A browser cookie is a small piece of data that is stored on your device to help websites and mobile apps remember things about you. Other technologies, including Web storage and identifiers associated with your device, may be used for similar purposes. In this policy, we say “cookies” to discuss all of these technologies.

Our Privacy Policy explains how we collect and use information from and about you when you use This website and certain other Innovative Publishing Co LLC services. This policy explains more about how we use cookies and your related choices.

How We Use Cookies

Data generated from cookies and other behavioral tracking technology is not made available to any outside parties, and is only used in the aggregate to make editorial decisions for the websites. Most browsers are initially set up to accept cookies, but you can reset your browser to refuse all cookies or to indicate when a cookie is being sent by visiting this Cookies Policy page. If your cookies are disabled in the browser, neither the tracking cookie nor the preference cookie is set, and you are in effect opted-out.

In other cases, our advertisers request to use third-party tracking to verify our ad delivery, or to remarket their products and/or services to you on other websites. You may opt-out of these tracking pixels by adjusting the Do Not Track settings in your browser, or by visiting the Network Advertising Initiative Opt Out page.

You have control over whether, how, and when cookies and other tracking technologies are installed on your devices. Although each browser is different, most browsers enable their users to access and edit their cookie preferences in their browser settings. The rejection or disabling of some cookies may impact certain features of the site or to cause some of the website’s services not to function properly.

Individuals may opt-out of 3rd Party Cookies used on IPC websites by adjusting your cookie preferences through this Cookie Preferences tool, or by setting web browser settings to refuse cookies and similar tracking mechanisms. Please note that web browsers operate using different identifiers. As such, you must adjust your settings in each web browser and for each computer or device on which you would like to opt-out on. Further, if you simply delete your cookies, you will need to remove cookies from your device after every visit to the websites. You may download a browser plugin that will help you maintain your opt-out choices by visiting www.aboutads.info/pmc. You may block cookies entirely by disabling cookie use in your browser or by setting your browser to ask for your permission before setting a cookie. Blocking cookies entirely may cause some websites to work incorrectly or less effectively.

The use of online tracking mechanisms by third parties is subject to those third parties’ own privacy policies, and not this Policy. If you prefer to prevent third parties from setting and accessing cookies on your computer, you may set your browser to block all cookies. Additionally, you may remove yourself from the targeted advertising of companies within the Network Advertising Initiative by opting out here, or of companies participating in the Digital Advertising Alliance program by opting out here.